Consequently, VEGF/VEGFR blockade is thought to exert an anti-tumor immunomodulatory effect and has been shown to reduce MDSCs in tumors and blood in both preclinical tumor models and human cancers (71). The gene discussed is KDR; the disease is neoplasm.